| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.41▼ | 1.42▼ | 1.42▼ | 1.43▼ | 1.43▼ |
| MA10 | 1.44▼ | 1.45▼ | 1.45▼ | 1.43▼ | 1.48▼ |
| MA20 | 1.44▼ | 1.44▼ | 1.44▼ | 1.44▼ | 1.70▼ |
| MA50 | 1.43▼ | 1.45▼ | 1.45▼ | 1.51▼ | 1.95▼ |
| MA100 | 1.48▼ | 1.50▼ | 1.50▼ | 1.75▼ | 2.15▼ |
| MA200 | 1.60▼ | 1.72▼ | 1.74▼ | 1.98▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | -0.006▼ | -0.006▼ | 0.003▲ | -0.023▼ |
| RSI | 37.441▼ | 37.037▼ | 37.070▼ | 37.459▼ | 37.998▼ |
| STOCH | 15.873▼ | 21.429 | 21.429 | 44.340 | 7.794▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ |
| CCI | -154.858▼ | -188.860▼ | -188.860▼ | -106.248▼ | -90.988 |
|
Thursday, July 30, 2026 06:43 AM
ImmunityBio (NASDAQ:IBRX) shares climbed 7.5% on Thursday after the company announced that the United Arab Emirates had granted marketing approval for ANKTIVA in two cancer indications, further ...
|
|
Wednesday, July 29, 2026 03:46 PM
ImmunityBio Receives United Arab Emirates (UAE) Marketing Authorization for ANKTIVA® Across BCG-Unresponsive Non-Muscle Invasive Bladder Cancer for CIS and Papillary Disease and Metastatic Non-Small ...
|
|
Wednesday, June 03, 2026 04:00 AM
SANTA CLARA, Calif., June 03, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate the deployment of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/08/26 | 1.37 | 1.4599 | 1.35 | 1.35 | 21,285 |
| 06/08/26 | 1.4506 | 1.46 | 1.41 | 1.41 | 15,889 |
| 05/08/26 | 1.5027 | 1.5027 | 1.48 | 1.48 | 7,597 |
| 04/08/26 | 1.4401 | 1.55 | 1.44 | 1.51 | 25,038 |
| 03/08/26 | 1.43 | 1.46 | 1.4115 | 1.42 | 11,754 |
| 31/07/26 | 1.46 | 1.46 | 1.42 | 1.45 | 17,263 |
| 30/07/26 | 1.4799 | 1.4799 | 1.41 | 1.45 | 17,920 |
| 29/07/26 | 1.42 | 1.4899 | 1.415 | 1.43 | 11,467 |
| 28/07/26 | 1.37 | 1.46 | 1.37 | 1.45 | 30,833 |
| 27/07/26 | 1.37 | 1.43 | 1.36 | 1.37 | 15,649 |
|
|
||||
|
|
||||
|
|